EN

Campuses

As France's leading biocluster, Genopole is an incubator for cutting-edge projects in biotechnology. Located in the city of Évry, just south of Paris, Genopole provides a unique environment for scientists and entrepreneurs seeking to advance research and innovation.

Discover >

Campus life

Discover the campuses

Advantages

Genopole accompanies researchers, postdocs and start-up entrepreneurs through all the phases of their projects to ensure the best possible conditions for business development.

Discover >

Join our programs

Shaker Gene.iO ATIGE

Genopole’s citizens

Every day, at Genopole, researchers, entrepreneurs and students cross paths, share ideas and unite forces in a veritable melting pot for innovation.

Discover >

Directories Our network

Highlights

Giving wings to research and empowering employment in our community are cornerstones of Genopole's mission. Catch up on recent scientific advances, the accomplishments of our biotech actors and the events that enliven the biocluster.

Discover >

Come to our events

Innovate with us

Discover >

Quick access

Company

Vitropep

Pépinière Genopole Entreprises
4, rue Pierre Fontaine – Campus 3
F-91000 EVRY

Mail: christophe.tarabout@vitropep.com
Christophe TARABOUT: President & CSO
Site Web >
Vitropep -entreprise genopole Vitropep -entreprise genopole

#Biotherapies #Medical device

  • Micro-needles
  • Chronic diseases
  • Peptides
  • Intradermic

Field of activity

Drug delivery, Healthcare.

BACKGROUND
Vitropep was created after an incubation in the Genopole Shaker program. Its technology is based on the scientific research of the founder.

DESCRIPTION OF THE PRODUCTS / SERVICES / TECHNOLOGY
Vitropep offers a patch of soluble microneedles made from therapeutic peptides for pain-free, dangerous waste-free and effortless intradermal injection. The aim is to improve the quality of life of patients suffering from chronic diseases such as diabetes.

CUSTOMER REFERENCES / COLLABORATIONS / HIGHLIGHTS
Vitropep completed the physicochemical proof of concept by fabricating various microneedles and testing their cell viability. Pharmacokinetic tests will start on two target therapeutic peptides while moving forward on a standardized patch. A first patent application has been filed. Vitropep has a collaboration with the CEA and also won Novo Nordisk Golden ticket.

COLLABORATIONS SOUGHT
Partnership for co development with pharmaceutical companies, startups and laboratories working in the field of injectable therapeutic peptide .

  • FURTHER INFORMATION

    1 patent pending

    STRENGHTS
    An easy, painless, waste-free injection

    INNOVATION ASSETS
    Unique technology allowing to inject certain peptides without cold chain and with self-administration.

Share
Companies directory

#Medical device

In the same field

Felome-entreprise Genopole

Felome

Felome has developed a customized genetic analysis approach using next-generation DNA sequencing technology.

Discover
CGenetix - Entreprise génopolitaine

CGenetix

CGenetix, is a medTech start-up developing in vitro medical diagnostic devices for the follow-up of transplant patients.

Discover
Floating Genes - entreprises génopolitaines

Floating Genes

Floating Genes develops diagnostic tools for use in liquid biopsies via the highly sensitive NGS detection of circulating tumor DNA.

Discover
View all >
With the support from
Région île de France
Ministère de l'Enseignement supérieur et de la recherche AFM-Téléthon
Communauté d'agglomération Grand Paris Sud
Département de l'Essonne - Terre D'avenirs Ville d'Evry-Courcouronnes 2023 CEA Inserm Centre hospitalier Sud Francilien Université d'Evry - Paris Saclay Université PAris-Saclay SEM Genopole

Keep up to date with Genopole’s latest events and news